American Century Companies’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164M | Sell |
2,617,803
-1,984,391
| -43% | -$159M | 0.08% | 244 |
|
|
2025
Q4 | $439M | Buy |
4,602,194
+603,088
| +15% | +$59.1M | 0.22% | 51 |
|
|
2025
Q3 | $390M | Sell |
3,999,106
-84,219
| -2% | -$8.72M | 0.2% | 64 |
|
|
2025
Q2 | $439M | Buy |
4,083,325
+195,947
| +5% | +$19.8M | 0.24% | 48 |
|
|
2025
Q1 | $392M | Sell |
3,887,378
-601,445
| -13% | -$60.6M | 0.24% | 52 |
|
|
2024
Q4 | $401M | Buy |
4,488,823
+925,268
| +26% | +$81.5M | 0.23% | 54 |
|
|
2024
Q3 | $299M | Buy |
3,563,555
+842,512
| +31% | +$66.4M | 0.17% | 92 |
|
|
2024
Q2 | $210M | Sell |
2,721,043
-554,264
| -17% | -$40.6M | 0.13% | 147 |
|
|
2024
Q1 | $224M | Sell |
3,275,307
-156,343
| -5% | -$10.1M | 0.14% | 145 |
|
|
2023
Q4 | $198M | Buy |
3,431,650
+159,840
| +5% | +$8.53M | 0.14% | 153 |
|
|
2023
Q3 | $173M | Buy |
3,271,810
+2,606,253
| +392% | +$137M | 0.13% | 166 |
|
|
2023
Q2 | $36M | Sell |
665,557
-64,224
| -9% | -$3.35M | 0.03% | 550 |
|
|
2023
Q1 | $36.5M | Buy |
729,781
+11,387
| +2% | +$537K | 0.03% | 521 |
|
|
2022
Q4 | $33.2M | Buy |
718,394
+14,380
| +2% | +$623K | 0.03% | 541 |
|
|
2022
Q3 | $27.3M | Buy |
704,014
+38,701
| +6% | +$1.55M | 0.02% | 561 |
|
|
2022
Q2 | $24.8M | Sell |
665,313
-56,206
| -8% | -$2.29M | 0.02% | 602 |
|
|
2022
Q1 | $32M | Buy |
721,519
+77,018
| +12% | +$3.34M | 0.02% | 566 |
|
|
2021
Q4 | $27.4M | Buy |
644,501
+6,313
| +1% | +$265K | 0.02% | 619 |
|
|
2021
Q3 | $27.7M | Sell |
638,188
-154
| -0% | -$6.81K | 0.02% | 608 |
|
|
2021
Q2 | $27.3M | Buy |
638,342
+14,043
| +2% | +$591K | 0.02% | 609 |
|
|
2021
Q1 | $24.1M | Sell |
624,299
-98,573
| -14% | -$3.73M | 0.02% | 609 |
|
|
2020
Q4 | $26M | Sell |
722,872
-9,193,625
| -93% | -$331M | 0.02% | 550 |
|
|
2020
Q3 | $379M | Sell |
9,916,497
-2,880,598
| -23% | -$111M | 0.34% | 65 |
|
|
2020
Q2 | $449M | Buy |
12,797,095
+3,086,713
| +32% | +$111M | 0.43% | 46 |
|
|
2020
Q1 | $317M | Buy |
9,710,382
+600,766
| +7% | +$23.5M | 0.38% | 60 |
|
|
2019
Q4 | $412M | Buy |
9,109,616
+591,070
| +7% | +$24.7M | 0.39% | 59 |
|
|
2019
Q3 | $347M | Buy |
8,518,546
+610,443
| +8% | +$25.9M | 0.35% | 76 |
|
|
2019
Q2 | $340M | Buy |
7,908,103
+3,505,662
| +80% | +$135M | 0.34% | 72 |
|
|
2019
Q1 | $169M | Buy |
4,402,441
+265,691
| +6% | +$10.1M | 0.17% | 168 |
|
|
2018
Q4 | $146M | Buy |
4,136,750
+34,818
| +0.8% | +$1.26M | 0.17% | 178 |
|
|
2018
Q3 | $158M | Buy |
4,101,932
+192,041
| +5% | +$6.71M | 0.15% | 188 |
|
|
2018
Q2 | $128M | Buy |
3,909,891
+901,586
| +30% | +$27.2M | 0.13% | 217 |
|
|
2018
Q1 | $82.2M | Sell |
3,008,305
-3,975,397
| -57% | -$108M | 0.08% | 288 |
|
|
2017
Q4 | $173M | Sell |
6,983,702
-3,512,787
| -33% | -$96.9M | 0.17% | 179 |
|
|
2017
Q3 | $306M | Buy |
10,496,489
+2,352,297
| +29% | +$65M | 0.31% | 90 |
|
|
2017
Q2 | $226M | Sell |
8,144,192
-616,192
| -7% | -$16.4M | 0.23% | 135 |
|
|
2017
Q1 | $218M | Sell |
8,760,384
-2,203,366
| -20% | -$53.6M | 0.23% | 134 |
|
|
2016
Q4 | $237M | Buy |
10,963,750
+2,359,924
| +27% | +$51.5M | 0.26% | 117 |
|
|
2016
Q3 | $205M | Sell |
8,603,826
-462,706
| -5% | -$11M | 0.23% | 129 |
|
|
2016
Q2 | $212M | Sell |
9,066,532
-4,390,662
| -33% | -$95M | 0.24% | 120 |
|
|
2016
Q1 | $253M | Buy |
13,457,194
+123,974
| +0.9% | +$2.18M | 0.3% | 92 |
|
|
2015
Q4 | $246M | Buy |
13,333,220
+117,537
| +0.9% | +$2.11M | 0.29% | 95 |
|
|
2015
Q3 | $217M | Buy |
13,215,683
+2,365,567
| +22% | +$40.4M | 0.26% | 103 |
|
|
2015
Q2 | $192M | Buy |
10,850,116
+5,717,949
| +111% | +$102M | 0.22% | 133 |
|
|
2015
Q1 | $91.1M | Sell |
5,132,167
-242,716
| -5% | -$3.84M | 0.1% | 269 |
|
|
2014
Q4 | $71.2M | Sell |
5,374,883
-1,005,161
| -16% | -$12.8M | 0.08% | 323 |
|
|
2014
Q3 | $75.3M | Buy |
6,380,044
+101,686
| +2% | +$1.28M | 0.09% | 282 |
|
|
2014
Q2 | $80.2M | Buy |
6,278,358
+470,838
| +8% | +$6.12M | 0.09% | 271 |
|
|
2014
Q1 | $78.5M | Sell |
5,807,520
-1,088,298
| -16% | -$14.3M | 0.09% | 271 |
|
|
2013
Q4 | $82.9M | Buy |
6,895,818
+260,639
| +4% | +$3.08M | 0.1% | 265 |
|
|
2013
Q3 | $77.9M | Sell |
6,635,179
-1,810,633
| -21% | -$19.6M | 0.1% | 266 |
|
|
2013
Q2 | $78.3M | Buy |
+8,445,812
| New | +$71.6M | 0.1% | 248 |
|
Other funds holding BSX
VCM
VPM
American Century Companies's BSX Position: Q1 2026 in Review
American Century Companies reduced its Boston Scientific (BSX) stake by 43% in Q1 2026, selling an estimated $159M and leaving 2,617,803 shares worth $164M. The position accounts for 0.08% of the portfolio, ranked #244.
American Century Companies first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $449M in Q2 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- American Century Companies held 2,617,803 shares of Boston Scientific worth $164M as of Q1 2026.
- American Century Companies sold 1,984,391 Boston Scientific shares in Q1 2026, an estimated $159M.
- Boston Scientific made up 0.08% of American Century Companies's portfolio in Q1 2026, its #244 holding.
- American Century Companies first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- American Century Companies's Boston Scientific position peaked at $449M in Q2 2020.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.